Explanation
Phaselbioequivalence study
Genericmedicinesare produced by companies whoaresubjecttothesametight manufacturing quality
controlsasthosewhomakebrandedproducts.Oftenthesamecompany makes bothbrandedandqeneric
medicines.A phase-lbioeauivalencestudv ensures thatthepharmacokineticpropertiesofthedruqare
acceptably similartotheoriainauproduct.incudinqthemaximumconcentration(C)theareaunderthe
curveAUC)andthetimeof maximumconcentrationt.Thereisnoneedtosubmttheentirebody of pre-
clinicaLresearch reauired for anew agent.
@1MINENDOCRINE
